 My name is John Coptrick, I'm a distinguished professor at Highly University. My appointment is to the Heritage College of Vosipathic Medicine. My lab's located in the Edison Biotechnology Institute. Everywhere that I go, I talk about John. It's almost unheard of that I would give a lecture or presentation to anybody without talking about John. I always highlight what he's done here and that helps us bring in the very best students, the very best faculty and the best researchers into our college. So John's work has elevated the college in almost anywhere that you look. My collaborators at ARHIS have been many and it's been going on since the mid-1990s. The first person I met, colleague, friend is Alan Flupor, who's now the Dean of the Medical School at ARHIS. And then in the mid-90s, I was just fascinating to meet a very, very good clinician, Jens Sandel Christensen. He and I were giving talks in different capitals of the countries in the world and we became friends and colleagues. And through him I was able to meet Jens Otto Jorgensen, a colleague of Jens Christensen. And together the three of us went on to plan successful collaborations. He has built a community of scholars, many of them from around the world. There's always a visiting scholar in there. He's got people coming in the lab all the time. He doesn't have the diversity, but he also has a group of students. He's got research scientists from all over and he really makes people enjoy being there. We now have currently, right now, a student from Yon First Steak. Her name is Rika Hartzberg. Excuse me if I got that name wrong. But she's now here working on adipose tissue from human samples and from mouse samples to see the effect of growth hormone. Are they the same in humans and mice or different? The drug that John invented has had a profound impact on medicine. Prior to somavert being invented, there was no drug that was specifically a growth hormone antagonist that would treat this condition called acromegaly. We were sitting around talking and he said, darling do you want to change the world? And I said, what are you talking about? No, not really. And he said, well if you don't want to change the world you need to get out of science. We do state of the art science as I told you. But we also have fun. So my colleague, when I go to visit in Arhos and after a day of talking science and doing scientific things, we'll always have a dinner somewhere together and have fun. And again it's the interaction of the science, the clinical aspects of the science and the personalities, the personal interactions, the fun that we have. That makes this an ideal collaboration. Please John, dear John, what a pleasant walk down memory lane. I really enjoyed it. And how I agree with you that the good basic state of art science, the clinically relevant science at fun, Moscow, hand in hand is really crucial. The English word serendipity may be translated into a pleasant surprise. As we heard you invented a very effective drug against the rare disease called acromegaly. And it is no secret that you actually discovered this growth hormone blogger by accident. I'll come back to that in a second. You originally planned out to develop a super active potent growth hormone to treat patients with dwarfism. But by a pleasant surprise, serendipity you developed a G8 blogger instead. In this way you are in my mind at least a state of the art example of why we researchers and academic institutions need time and financial support for independent research. This allows the crazy idea to develop the unexpected results to be discovered as in your case. In your case you actually unexpectedly discovered a thing that turned into a drug that now helps thousands of patients all over the world. So it is there for on this background my privilege and pleasure to bestow on you the degree Doctor Medicina at Aarhus University, a personal pleasure actually. And I'll start off giving you a hug actually.